The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Acer Therapeutics Inc(NASDAQ:ACER) 
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates: EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients ...
Acer Therapeutics Days Payable Outstanding ttm (DPO)
Acer Therapeutics Days Inventory Outstanding ttm (DIO)
Acer Therapeutics Op Cashflow Per Share ttm
Acer Therapeutics Free Cashflow Per Share ttm
Acer Therapeutics Cash Per Share ttm
Acer Therapeutics P/S ratio ttm
Acer Therapeutics (GAAP) P/E ratio ttm
Acer Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.